These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1706796)

  • 1. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.
    Varró A; Lathrop DA
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):557-67. PubMed ID: 1706796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.
    Lathrop DA; Varró A
    Br J Pharmacol; 1990 Jan; 99(1):124-30. PubMed ID: 2331566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the cellular electrophysiology of mexiletine and sotalol, singly and combined, in canine Purkinje fibers.
    Berman ND; Loukides JE
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):286-92. PubMed ID: 2464100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. I. Alteration of mexiletine-induced Vmax depression.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):416-22. PubMed ID: 2177359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate-dependent electrophysiological effects of OPC-8212: comparison to sotalol.
    Lathrop DA; Varró A; Schwartz A
    Eur J Pharmacol; 1989 May; 164(3):487-96. PubMed ID: 2767119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine Purkinje fibres.
    Varrò A; Knilans TK; Nànàsi PP; Rabloczky G; Lathrop DA
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):691-7. PubMed ID: 2096301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
    Opincariu M; Varró A; Iost N; Virág L; Hála O; Szolnoki J; Szécsi J; Bogáts G; Szenohradszky P; Mátyus P; Papp JG
    Curr Med Chem; 2002 Jan; 9(1):41-6. PubMed ID: 11860346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from use-dependent block of Vmax and restitution of action potential duration in canine cardiac Purkinje fibers.
    Elharrar V
    J Pharmacol Exp Ther; 1988 Jul; 246(1):235-42. PubMed ID: 3392655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of the electrophysiologic effects of mexiletine in canine Purkinje fibers alters the response to subsequent hypoxia.
    Berman ND; Ogilvie RI; Loukides JE
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2104-9. PubMed ID: 3427544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.
    Knilans TK; Lathrop DA; Nánási PP; Schwartz A; Varró A
    Br J Pharmacol; 1991 Jun; 103(2):1568-72. PubMed ID: 1884111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular electropharmacology of the simultaneous administration of propranolol and mexiletine: a class I and II antiarrhythmic drug combination.
    Berman ND; Loukides JE
    J Electrocardiol; 1987 Nov; 20(5):297-302. PubMed ID: 3430100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
    J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands.
    Lathrop DA
    Can J Physiol Pharmacol; 1985 Dec; 63(12):1506-12. PubMed ID: 3830350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
    Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol on premature action potentials in canine Purkinje and ventricular muscle.
    Varró A; Lathrop DA; Surawicz B
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):757-63. PubMed ID: 1703597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.